ROLE OF MRI IN DETECTING ABNORMAL PLACENTATION IN PATIENTS WITH STRONG ULTRASOUND CONCERN FOR MYOMETRIAL INVASION

Ummara Siddique Umer, Syed Ghulam Ghaus, Shahjehan Alam, Seema Gul, Aman Nawaz Khan, Sadia Gul, Hadia Abid, Abdullah Safi, Muhammad Shahjahan Khurshidi, Muhammad Naveed

Abstract


BACKGROUND:Placenta accreta is a severe pregnancy complication which occurs when the chorionic villi invade the myometrium abnormally. Its increasing incidence has greatly increased the risk of a possible threat to life. Previous damage to myometrial wall, through prior cesarean section is the most important risk factor for the development of placenta accreta. MRI increases the accuracy of the workup of high-risk patients and aids in multidisciplinary delivery planning to improve maternal outcome. PURPOSE: The purpose of this study was to identify the role of MRI for diagnosis of morbidly adherent placenta and to assess its depth of invasion in patients with ultrasound suspicion of accreta. The other purpose was to establish the ideal MR sequence perfect for diagnosing placental invasiveness.  PATIENTS AND METHODS: This is a prospective cross sectional analysis to identify morbidly adherent placenta, in patients who presented for MRI placenta from 1st January 2016 to 30 May 2017 at Radiology department of Rehman Medical Institute Peshawar. 14 patients were included with age range of 20-38 years and mean gestational age of 36 weeks. Included patients had sonographic findings suspicious for placenta accreta and were referred for MRI to confirm the diagnosis. The other indications for MR evaluation of the placenta included a lack of adequate visualization of the placenta on prenatal sonography; multiple previous cesarean deliveries with or without concomitant vaginal bleeding; anterior placenta with poor visualization of the region of the cesarean scar on sonography; multiple cesarean deliveries with anterior or low lying placenta and advanced maternal age; and anterior placenta with focal loss of the retroplacental myometrial zone on ultrasound, raising concern for placenta accreta.  MRI was performed on 1.5 tesla GE machine. Multiplanar T2 PROP, T2 FATSAT, T1 and T2 2D FISETA images were acquired. MR images were assessed and re-evaluated by two radiologists with experience in reading pelvic MRI who were blinded to the final diagnosis, especially the site suspicious for placental adhesion. MRI diagnostic criteria for morbidly adherent placenta were established with consensus.  In patients who were operated at our institute, the surgical findings were correlated retrospectively with the MRI findings. RESULTS: MRI confirmed morbidly adherent placenta in 93% of pregnant females with ultrasound suspicion of accreta. Placenta previa was seen in 92%. Placenta was anterior in 42%, Completely low lying in 28.5% and posterior in 28.5%. The most common type of placental invasiveness grade was Increta. MRI was more sensitive than US for the detection of depth of myometrial invasion and the type of abnormal placentation. MRI findings favoring placental invasiveness included: Placental heterogeneity, T2 low bands, Loss of placental - myometrial interface, Traversing vessels, Bulging placenta / uterine bulge, Thin bulging serosa, Direct invasion into or beyond the serosa or Bladder tenting. CONCLUSION: We conclude from our results that MRI confirmed morbidly adherent placenta in 93% patients. The most common grade of invasive placenta on MRI was Increta. T2-PROP is the imaging sequence of choice for Percreta and Increta and T2-FIESTA was found to be useful for Accreta. KEYWORDS: Magnetic Resonance Imaging (MRI), Ultrasound, Placenta percreta, increta, accreta, Morbidly adherent Placenta (MAP).


Full Text:

PDF

References


Sunil A, Somya A. Placenta Accreta Prenatal Diagnosis: Does MRI add to Sonography?. J Gynecol Women’s Health. 2016; 1(4): 555569.

Varghese B, Singh N, George RA, Gilvaz S. Magnetic resonance imaging of placenta accreta. The Indian Journal of Radiology & Imaging. 2013;23(4):379-85.

Sulatana N, Mohyuddin S, Riaz M, Niaz WA, Murtaza B. Management of placenta percreta with bladder invasion. J Pioneer Med Sci. 2015; 5(1):31-3.

Kilcoyne A, Shenoy-Bhangle AS, Roberts DJ, Sisodia RC, Gervais DA, Lee SI. MRI of Placenta Accreta, Placenta Increta, and Placenta Percreta: Pearls and Pitfalls. American Journal of Roentgenology 2017 208:1, 214-21.

Blaicher W, Brugger PC, Mittermayer C, Schwindt J, Deutinger J, Bernaschek G, et al. Magnetic resonance imaging of the normal placenta. Eur J Radiol. 2006;57:256–60.

Derman AY, Nikac V, Haberman S, Zelenko N, Opsha O, Flyer M. MRI of placenta accreta: a new imaging perspective.AJR Am J Roentgenol. 2011 Dec; 197(6):1514-21.

Lax A, Prince MR, Mennitt KW, Schwebach JR, Budorick NE. The value of specific MRI features in the evaluation of suspected placental invasion. Magn Reson Imaging. 2007 Jan; 25(1):87-93.

Teo TH, Law YM, Tay KH, Tan BS, Cheah FK. Use of magnetic resonance imaging in evaluation of placental invasion. Clin Radiol. 2009 May; 64(5):511-6.

Usta IM, Hobeika EM, Musa AA, Gabriel GE, Nassar AH. Placenta previa-accreta: risk factors and complications. Am J Obstet Gynecol 2005;193:1045-9.

Dwyer BK, Belogolovkin V, Tran L, Rao A, Carroll I, Barth R, Chitkara U. Prenatal Diagnosis of Placenta Accreta: Sonography or Magnetic Resonance Imaging? Journal of ultrasound in medicine: official journal of the American Institute of Ultrasound in Medicine. 2008;27(9):1275-81.

Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol. 1997 Jul; 177(1):210-4.

ACOG Committee on Obstetric Practice. ACOG Committee opinion. Number 266, January 2002 : placenta accreta. Obstet Gynecol 2002;99:169–70.

Blanchette H. The rising cesarean delivery rate in America: what are the consequences? Obstet Gynecol (2011) 118(3): 687-90.

Haider G, Zehra N,Munir AA. Frequency and indications of caesarean section in tertiary care hospital. Pak .J ,Med.Sci 2009; 5: 791-6.

Gielchinsky Y, Rojansky N, Fasouliotis SJ, Ezra Y. Placenta accreta--summary of 10 years: a survey of 310 cases. Placenta 2002;23: 210-14.

Morken NH, Henriksen H. Placenta percreta,two cases and review of the literature. Eur. J.obstet Gynecol Reprod. Biol. 2001;100: 112 –5.

Aitken K, Allen L, Pantazi S, Kingdom J, Keating S, Pollard L et al. MRI Significantly Improves Disease Staging to Direct Surgical Planning for Abnormal Invasive Placentation: A Single Centre Experience. 2016 J Obstet Gynaecol Can 38(3): 246-51.

Algebally AM, Yousef RR, Badr SS, Al Obeidly A, Szmigielski W, Al Ibrahim AA. The Value of Ultrasound and Magnetic Resonance Imaging in Diagnostics and Prediction of Morbidity in Cases of Placenta Previa with Abnormal Placentation. 2014. Pol J Radiol 79: 409-16.

D'Antonio F, Iacovella C, Palacios-Jaraquemada J, Bruno CH, Manzoli L, Bhide A. Prenatal identification of invasive placentation using magnetic resonance imaging: systematic review and meta-analysis. 2014. Ultrasound Obstet Gynecol 44(1): 8-16.

Lam G, Kuller J, McMahon M. Use of magnetic resonance imaging and ultrasound in the antenatal diagnosis of placenta accreta. J Soc Gynecol Investig. 2002 Jan-Feb; 9(1):37-40.

Warshak CR, Eskander R, Hull AD, Scioscia AL, Mattrey RF, Benirschke K, Resnik R. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol. 2006 Sep; 108(3 Pt 1):573-81.

Kanal E, Borgstede JP, Barkovich AJ, Bell C, Bradley WG, Etheridge S et al. American College of Radiology White Paper on MR Safety: 2004 update and revisions. American College of Radiology. AJR Am J Roentgenol. 2004 May; 182(5):1111-4.

A Kanal E, Barkovich AJ, Bell C, Borgstede JP, Bradley WG Jr, Froelich JW et al. ACR guidance document for safe MR practices: 2007. ACR Blue Ribbon Panel on MR Safety. AJR Am J Roentgenol. 2007 Jun; 188(6):1447-74.


Refbacks

  • There are currently no refbacks.


© Copyright PJR 2008-